Undecimal Bio
Undecimal Bio is a biotechnology company developing an AI-driven platform for targeted siRNA drug delivery.
Funding
Every round, secondary, debt facility or acquisition involving Undecimal Bio that Lounge tracks, newest first. Latest: Seed on Oct 12, 2026.
Timeline · 1
Round
Seed · $18M at $81M
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $37/mo.
See plans →Log in